FOXP3 Luciferase Reporter-Jurkat Cell Line

reporter cell line

Product Info Summary

SKU: RC1044
Size: 1 Vial, Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO.
Application: Functional Assay

Product Name

FOXP3 Luciferase Reporter-Jurkat Cell Line

SKU/Catalog Number

RC1044

Size

1 Vial, Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO.

Description

The FOXP3 Luciferase Reporter cell line is a stably transfected Jurkat T cell line which expresses Renilla luciferase reporter gene under the transcriptional control of the Forkhead box P3 (FOXP3) promoter. As a member of the forkhead transcription factor family, FOXP3 is a key transcription factor that functions in the development and function of regulatory T cells. Functional activity of the cell line has been validated by phorbol 12-myristate 13-acetate (PMA) in the presence of ionomycin (Figure 1). 

Contents

Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO.

Storage & Handling

Immediately upon receipt, store in liquid nitrogen. (Ship on dry ice.)

Cite This Product

FOXP3 Luciferase Reporter-Jurkat Cell Line (Boster Biological Technology, Pleasanton CA, USA, Catalog # RC1044)

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. Actual working concentration varies and should be decided by the user.

Application:

Monitor the FOXP3 induction activity.Screen for activators or inhibitors of FOXP3 indction. 

Culture conditions:

 Cells should be grown at 37°C with 5% CO2 using RPMI medium supplemented with 10% FBS, 1 mM sodium pyruvate, 10 mM HEPES and 1% Pen/Strep plus 3 µg/ml of Puromycin. It is recommended to quickly thaw the frozen cells upon receipt or from liquid nitrogen in a 37°C water-bath, transfer to a tube containing 10 ml of growth medium without Puromycin, spin down cells, resuspend cells in pre-warmed growth medium without Puromycin, transfer resuspended cells to T25 flask and culture in 37°C-CO2 incubator.  Monitor the cell viability by counting cells daily for 1~3 days until cells completely recover viability as cells are doubling daily. Once cells are over 90% confluent, harvest cells by centrifugation and passage cells. At first passage, switch to growth medium containing Puromycin. Cells should be split before they reach complete confluence. To passage the cells, transfer cells to a tube, spin down cells, resuspend cells and seed appropriate aliquots of cell suspension into new culture vessels. Subcultivation ration = 1:10 to 1:20 weekly.

Functional validation:

A. Response of FOXP3 Jurkat T cells to phorbol 12-myristate 13-acetate (PMA)/ Ionomycin.1. Harvest FOXP3 Jurkat T cells and seed cells into a white solid-bottom 96-well microplate in 100 µl of growth medium at 2.5 x 10^5 cells/well.  

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used FOXP3 Luciferase Reporter-Jurkat Cell Line?

Submit a review and receive an Amazon gift card.

  • $30 for a review with an image

0 Reviews For FOXP3 Luciferase Reporter-Jurkat Cell Line

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for FOXP3 Luciferase Reporter-Jurkat Cell Line

$2072
Backordered.

Lead time for this item is typically 4-6 days

Get A Quote
In stock
Order Product
RC1044
$2,072.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Apr 2, 2026